Bridging Sunitinib Exposure to Time‐to‐Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker

por Ait‐Oudhia, S, Mager, DE, Pokuri, V, Tomaszewski, G, Groman, A, Zagst, P, Fetterly, G, Iyer, R
Publicado 2016